☆ 4.7 Review

Maternal COVID-19 Vaccine May Reduce the Risk of MIS-C in Infants: A Narrative Review

VACCINES (2022)

Related references

Note: Only part of the references are listed.

Review Medical Laboratory Technology

MultiInflammatory Syndrome in Children: A View into Immune Pathogenesis from a Laboratory Perspective

Mary Kathryn Bohn et al.

Summary: MIS-C presents unique inflammatory signatures involving adaptive and innate systems. Laboratory testing plays a crucial role in the diagnosis and monitoring of MIS-C. There are major gaps in understanding MISC pathogenesis and long-term health outcomes.

JOURNAL OF APPLIED LABORATORY MEDICINE (2022)

Add to Collection

Letter Obstetrics & Gynecology

Newborns' passive humoral SARS-CoV-2 immunity following heterologous vaccination of the mother during pregnancy

Stefan Gloeckner et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)

Add to Collection

Letter Medicine, General & Internal

Multisystem Inflammatory Syndrome in Children by COVID-19 Vaccination Status of Adolescents in France

Michael Levy et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Add to Collection

Letter Medicine, General & Internal

Durability of Anti-Spike Antibodies in Infants After Maternal COVID-19 Vaccination or Natural Infection

Lydia L. Shook et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Add to Collection

Article Obstetrics & Gynecology

Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery

Yawei J. Yang et al.

Summary: Vaccination against COVID-19 during pregnancy resulted in detectable levels of maternal and umbilical cord anti-spike IgG at delivery. A complete vaccination course, prior history of SARS-CoV-2 infection, and a third-trimester booster dose were associated with the highest levels of maternal and umbilical cord antibodies.

OBSTETRICS AND GYNECOLOGY (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021

Laura D. Zambrano et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19–Associated Hospitalization in Infants Aged

Natasha B. Halasa et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

Add to Collection

Editorial Material Pediatrics

Neonatal Multisystem Inflammatory Syndrome secondary to SARS-CoV-2 infection

Shivshankar Diggikar et al.

JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2022)

Add to Collection

Article Medicine, General & Internal

BNT162b2 Protection against the Omicron Variant in Children and Adolescents

A. M. Price et al.

Summary: In this study evaluating BNT162b2, vaccine effectiveness against hospitalization for Covid-19 in the delta-predominant period among adolescents 12 to 18 years of age was more than 90%; during the omicron period, vaccine effectiveness was 40% against hospitalization and 79% against critical illness. Vaccine effectiveness against hospitalization was 68% among children 5 to 11 years of age.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Editorial Material Pediatrics

COVID-19 Vaccines: Safe and Effective in Children Aged 5 to 11 Years

Sara E. Oliver et al.

PEDIATRICS (2022)

Add to Collection

Review Virology

Multisystem Inflammatory Syndrome in Neonates Born to Mothers with SARS-CoV-2 Infection (MIS-N) and in Neonates and Infants Younger Than 6 Months with Acquired COVID-19 (MIS-C): A Systematic Review

Domenico Umberto De Rose et al.

Summary: This study reviewed the clinical features of multisystem inflammatory syndrome in neonates and infants under six months of age. It found that cardiovascular dysfunction and respiratory distress were the prevalent findings in both MIS-N and MIS-C cases. Therefore, it is recommended to perform echocardiography on suspected infants with inflammatory diseases, and a therapeutic algorithm is provided for their management.

VIRUSES-BASEL (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Hospitalization of Infants and Children Aged 0–4 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022

Kristin J. Marks et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022

Ashley L. Fowlkes et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022

Nicola P. Klein et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Hospitalizations of Children Aged 5–11 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022

Dallas S. Shi et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

Add to Collection

Article Health Care Sciences & Services

Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post- authorization pharmacovigilance study

Naim Ouldali et al.

Summary: Very few cases of hyper-inflammatory syndrome with multi-organ involvement occurred following COVID-19 mRNA vaccine in 12-17-year-old children. The low reporting rate of this syndrome, compared to the rate of post-SARS-CoV-2 MIS-C in the same age-group, largely supports the vaccination in a context of an important circulation of SARS-CoV-2.

LANCET REGIONAL HEALTH-EUROPE (2022)

Add to Collection

Article Obstetrics & Gynecology

Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies among parturient women treated with BNT162b2 messenger RNA vaccine during pregnancy

Omer Nir et al.

Summary: This study found that SARS-CoV-2 immunoglobulin G can efficiently transfer across the placenta from pregnant women vaccinated with the BNT162b2 mRNA vaccine to their neonates. There was a positive correlation between antibody concentrations in maternal and cord blood, indicating potential neonatal humoral immunity provided by maternal vaccination.

AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM (2022)

Add to Collection

Article Pediatrics

Neonatal Multisystem Inflammatory Syndrome (MIS-N) Associated with Prenatal Maternal SARS-CoV-2: A Case Series

Ravindra Pawar et al.

Summary: A study in India reviewed the perinatal history, clinical features, and outcomes of 20 neonates born between September 2020 and April 2021, all of whom exhibited symptoms consistent with Multisystem Inflammatory Syndrome in Children (MIS-C) related to maternal SARS-CoV-2. Most neonates showed cardiac involvement and were treated with steroids and IVIG, with two infants unfortunately passing away due to worsening condition.

CHILDREN-BASEL (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children

Tarek Alsaied et al.

Summary: Multisystem inflammatory syndrome in children, triggered by SARS-CoV-2 infection, is a severe inflammatory disease with common symptoms of persistent fever and cardiac manifestations. Treatment mainly aims at reversing the inflammatory response with immunomodulatory medications.

CIRCULATION (2021)

Add to Collection

Article Pediatrics

Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States

L. Charles Bailey et al.

Summary: This cohort study of US pediatric patients found low rates of SARS-CoV-2 infection, with mild clinical manifestations. Infection was associated with Black, Hispanic, and Asian race/ethnicity, adolescence and young adulthood, as well as non-respiratory chronic medical conditions. The study suggests higher concern may be warranted for patients with complex medical conditions or minority race/ethnicity.

JAMA PEDIATRICS (2021)

Add to Collection

Article Obstetrics & Gynecology

Titers of SARS CoV-2 antibodies in cord blood of neonates whose mothers contracted SARS CoV-2 (COVID-19) during pregnancy and in those whose mothers were vaccinated with mRNA to SARS CoV-2 during pregnancy

Lior Kashani-Ligumsky et al.

Summary: Newborns born to mothers vaccinated during pregnancy have higher antibody titers, potentially providing longer protection compared to those born to women infected during pregnancy.

JOURNAL OF PERINATOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19

Leora R. Feldstein et al.

Summary: Comparing the clinical characteristics and outcomes of patients with MIS-C and COVID-19 can help distinguish between the two conditions and improve health outcomes. Patterns of clinical presentation and organ system involvement were identified in this case series, providing valuable information for differentiation of MIS-C and COVID-19.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Obstetrics & Gynecology

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies in Neonatal Cord Blood After Vaccination in Pregnancy

Lisa Gill et al.

Summary: In this case, it was demonstrated that transplacental antibodies for SARS-CoV-2 were passed after vaccination in the third trimester of pregnancy.

OBSTETRICS AND GYNECOLOGY (2021)

Add to Collection

Article Obstetrics & Gynecology

Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study

Kathryn J. Gray et al.

Summary: The study found that pregnant and lactating women had equivalent antibody titers after receiving the coronavirus disease 2019 mRNA vaccine compared to nonpregnant women, and these titers were higher than those induced by natural infection. Vaccine-induced antibodies were present in umbilical cord blood and breastmilk samples, transferring immunity to neonates through placenta and breastmilk.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)

Add to Collection

Editorial Material Obstetrics & Gynecology

Cord blood antibodies following maternal coronavirus disease 2019 vaccination during pregnancy

Leena B. Mithal et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)

Add to Collection

Article Pediatrics

Newborn antibodies to SARS-CoV-2 detected in cord blood after maternal vaccination - a case report

Gilbert Paul et al.

Summary: This is the first known case of an infant with detectable SARS-CoV-2 IgG antibodies in cord blood after maternal vaccination.

BMC PEDIATRICS (2021)

Add to Collection

Article Immunology

Efficient Maternofetal Transplacental Transfer of Anti- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Antibodies After Antenatal SARS-CoV-2 BNT162b2 Messenger RNA Vaccination

Amihai Rottenstreich et al.

Summary: The study showed that both maternal and neonatal protection were provided by antenatal vaccination with the BNT162b2 vaccine. Specific antibodies were detected in both maternal and cord blood, with concentrations correlating to maternal levels and time since vaccination.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12–18 Years — United States, June–September 2021

Samantha M. Olson et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Characteristics and Clinical Outcomes of Children and Adolescents Aged

Valentine Wanga et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Add to Collection

Article Immunology

Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children

Anjali Ramaswamy et al.

Summary: Through various analyses, specific biological features were identified in MIS-C patients, including myeloid dysfunction, elevated cytotoxicity gene expression in NK and CD8(+) T cells, and autoimmune characteristics, which could potentially improve the diagnosis and prediction of disease severity in MIS-C.

IMMUNITY (2021)

Add to Collection

Article Medicine, General & Internal

Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women

Ai-ris Y. Collier et al.

Summary: This study assessed the immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women, as well as the responses against emerging SARS-CoV-2 variants. The results showed that pregnant, lactating, and nonpregnant women developed antibody and T-cell responses following vaccination, with antibodies transferred to infant cord blood and breast milk. While antibody titers against the B.1.1.7 and B.1.351 variants were reduced, T-cell responses remained against the viral variants.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Medicine, General & Internal

Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons

Tom T. Shimabukuro et al.

Summary: Preliminary data indicates that there are no obvious safety signals among pregnant women who received mRNA Covid-19 vaccines, but more data is needed for further confirmation. Adverse reactions such as injection-site pain were reported more frequently in pregnant women, but most pregnancies resulted in live births with some cases of preterm birth and small size for gestational age.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Editorial Material Pediatrics

Maternal COVID-19 vaccine antibody response and passage into cord blood

Kathryn J. Gray

JOURNAL OF PEDIATRICS (2021)

Add to Collection

Article Pediatrics

Trends in Geographic and Temporal Distribution of US Children With Multisystem Inflammatory Syndrome During the COVID-19 Pandemic

Ermias D. Belay et al.

Summary: This study conducted a cross-sectional analysis of a large cohort of patients with MIS-C in the United States, identifying 2 peaks that followed COVID-19 peaks by 2 to 5 weeks. The geographic and temporal association of MIS-C with the COVID-19 pandemic suggested that MIS-C resulted from delayed immunologic responses to SARS-CoV-2 infection. Clinical manifestations varied by age and presence or absence of preceding COVID-19.

JAMA PEDIATRICS (2021)

Add to Collection

Article

BNT162b2 Vaccination during Pregnancy Protects Both the Mother and Infant: Anti-SARS-CoV-2 S Antibodies Persistently Positive in an Infant at 6 Months of Age

Chetna Mangat et al.

Case Reports in Pediatrics (2021)

Add to Collection

Letter Nursing

Successful vertical transmission of SARS-CoV-2 antibodies after maternal vaccination

Jacob H. Mehaffey et al.

BIRTH-ISSUES IN PERINATAL CARE (2021)

Add to Collection

Letter Infectious Diseases

Both SARS-CoV-2 infection and vaccination in pregnancy elicited neutralizing antibodies in pregnant women and newborns

Irene Cassaniti et al.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Add to Collection

Article Medicine, General & Internal

Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes

Mary Beth F. Son et al.

Summary: Initial treatment with IVIG plus glucocorticoids was associated with a lower risk of cardiovascular dysfunction compared to IVIG alone in children with MIS-C.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Immunology

Polyclonal expansion of TCR Vβ 21.3+ CD4+ and CD8+ T cells is a hallmark of multisystem inflammatory syndrome in children

Marion Moreews et al.

Summary: MIS-C is characterized by increased serum inflammatory cytokines and a specific expansion of activated T cells expressing the V.21.3 T cell receptor beta chain variable region, not directed against SARS-CoV-2 antigenic peptides, which differentiates it from KD, TSS, and acute COVID-19. The T cell repertoire returns to baseline soon after MIS-C resolution.

SCIENCE IMMUNOLOGY (2021)

Add to Collection

Article Immunology

Efficient Maternal to Neonate Transfer of Neutralizing Antibodies after SARS-CoV-2 Vaccination with BNT162b2: A Case-Report and Discussion of the Literature

Jonathan Douxfils et al.

Summary: The successful transfer of neutralizing antibodies from a pregnant woman to her fetus after vaccination suggests that these antibodies have specific characteristics related to their neutralizing capacity. Vaccination against COVID-19 in pregnancy is important for controlling disease burden and improving outcomes in both the mother and the fetus. Including pregnant women in research programs for vaccine development is crucial to ensure equitable benefits for this population.

VACCINES (2021)

Add to Collection

Article Immunology

Evaluation of SARS-CoV-2 Spike Protein Antibody Titers in Cord Blood after COVID-19 Vaccination during Pregnancy in Polish Healthcare Workers: Preliminary Results

Wojciech Zdanowski et al.

Summary: This study aimed to evaluate the transfer of antibodies between mothers and infants after COVID-19 vaccination during pregnancy. The results showed high levels of antibodies in all analyzed mother-infant pairs, with a correlation between antibody transfer and the timing of vaccination to delivery.

VACCINES (2021)

Add to Collection

Article Medicine, Research & Experimental

Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine

Ofer Beharier et al.

Summary: The study demonstrates that the BNT162b2 mRNA vaccine induces a strong maternal IgG response that crosses the placenta barrier to reach fetal titers within 15 days of the first dose. The transfer ratio of anti-COVID-19 antibodies from mother to neonate differs between vaccination and infection groups, with lower IgG transfer ratio for third-trimester compared to second-trimester infection. Additionally, fetal IgM response was only detected in neonates from the infected group.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection

Letter Obstetrics & Gynecology

High antibody levels in cord blood from pregnant women vaccinated against COVID-19

Megan E. Trostle et al.

AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM (2021)

Add to Collection

Article Infectious Diseases

Maternal immunisation: collaborating with mother nature

Arnaud Marchant et al.

LANCET INFECTIOUS DISEASES (2017)

Add to Collection

© Peeref 2019-2024. All rights reserved.